Duque Santana, VíctorFernández, JulioLópez Campos, FernandoDíaz Gavela, Ana AuroraRecio Rodríguez, ManuelGuerrero Gómez, Luis LeonardoPeña Huertas, MarinaThuissard Vasallo, Israel JohnSanz Rosa, DavidCerro Peñalver, Elia delCouñago Lorenzo, FelipeEt.al.2026-02-172026-02-172025Duque-Santana, V., Fernandez, J., López-Campos, F., Diaz-Gavela, A., Recio, M., Guerrero, L. L., Peña, M., Sanchez, S., Thuissard, I. J., Andreu-Vázquez, C., Sanz-Rosa, D., Marvaso, G., Gómez-Iturriaga, A., Zilli, T., Del Cerro, E., & Couñago, F. (2025). Integrating apparent diffusion coefficient and prostate-specific antigen as prognostic factors of treatment response to androgen deprivation therapy and radiotherapy in prostate cancer. Biomedicines, 13(8), 1979. https://doi.org/10.3390/biomedicines130819792227-9059https://hdl.handle.net/11268/16823This study evaluates the combined prognostic value of the apparent diffusion coefficient (ADC) from multiparametric MRI (mpMRI) and prostate-specific antigen (PSA) levels at 6 months post-radiotherapy (RT) in assessing treatment response in prostate cancer patients treated with RT and androgen deprivation therapy (ADT).engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Neoplasias de la PróstataRadioterapiaFactor Pronósticojournal article10.3390/biomedicines13081979open accessCáncerInvestigación médicaTratamiento médicoGoal 3: Ensure healthy lives and promote well-being for all at all ages